NEWS RELEASE
28 January 2015
THE BIOTECH GROWTH TRUST PLC
(the "Company")
SALE OF COMPANY'S OWN SHARES FROM TREASURY
Notification is given pursuant to the authority granted at the Annual General
Meeting of the Company held on 10 July 2014 to sell shares held by the Company
up to an aggregate nominal value of £1,696,943, representing 10 per cent. of
the issued ordinary share capital of the Company, that a market total of 30,000
Ordinary shares of 25p each has been sold by the Company on 28 January 2015 out
of treasury, at a price of 774.75p per share which equates to an estimated
premium to net asset value per share at the time of sale of 2.00%.
As a result the Company now holds 5,027,831 shares in treasury. The total
number of Ordinary shares that the Company has in issue following such sale is
68,886,347. Therefore, the total number of voting rights in the Company is
63,858,516.
For and on behalf of
Frostrow Capital LLP
Company Secretary
For further information, please contact:
Victoria Hale
Frostrow Capital LLP
Tel: 020 3 170 8732
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.